Intranasal delivery of engineered anti-SARS-CoV-2 extracellular vesicles therapeutically represses lung infection and inflammation
经鼻内递送工程化抗SARS-CoV-2细胞外囊泡可有效抑制肺部感染和炎症。
期刊:Drug Delivery and Translational Research
影响因子:5.5
doi:10.1007/s13346-025-01922-9
Idris, Adi; Shrivastava, Surya; Gao, Wenqing; Supramaniam, Aroon; Tayyar, Yaman; West, Nicholas P; Kelly, Gabrielle; Acharya, Dhruba; McMillan, Nigel A J; Morris, Kevin V